期刊文献+

下调泛素蛋白连接酶E3A表达对三阴性乳腺癌细胞生物学行为的影响 被引量:2

Effects of down-regulating expression of ubiquitin-protein ligase E3A on biological behaviors in three negative breast cancer cells
原文传递
导出
摘要 目的:探讨降低泛素蛋白连接酶E3A(UBE3A)的表达对三阴性乳腺癌细胞生物学行为的影响。方法:采用慢病毒载体分别将构建的3条UBE3A shRNA序列转染人三阴性乳腺癌细胞株MDAMB-231,检测干扰效率后,筛选出干扰效率最高的序列用于实验。分别采用CCK8法、Transwell小室实验、流式细胞术观察MDA-MB-231细胞经所选用的UBE3A shRNA序列转染后侵袭能力、增殖能力与细胞周期的变化,以转染阴性对照组序列和无处理的MDA-MB-231细胞作为阴性对照及空白对照。结果:成功构建UBE3A shRNA慢病毒表达载体并筛选出干扰率最高的UBE3A shRNA序列(UBE3A基因和蛋白表达抑制率分别为89.5%、45.3%)。与空白对照组细胞比较,下调UBE3A的MDAMB-231细胞的增殖、侵袭能力均明显降低,且细胞周期出现明显的S期阻滞(均P<0.05);阴性对照组细胞各项观察指标无统计学差异(均P>0.05)。结论:下调UBE3A表达能诱导三阴性乳腺癌细胞的细胞周期阻滞,从而抑制其增殖与侵袭能力,提示UBE3A在三阴性乳腺癌细胞的恶性生物学行为中发挥了重要作用。 Objective: To investigate the effects of down-regulating the expression of ubiquitin-protein ligase E3 A(UBE3 A) on the biological behaviors in three negative breast cancer(TNBC) cells.Methods: Three constructed UBE3 A shRNA sequences were respectively transfected into the human TNBCMDA-MB-231 cells through lentiviral vectors, and the shRNA sequence with highest interference efficiency was selected for experiments after interference efficiency tests. In MDA-MB-231 cells after transfected with the selected UBE3 A shRNA sequence, the changes in proliferation, invasion and cell cycle were determined by CCK-8 assay, Transwell invasion assay and flow cytometry respectively, using the MDA-MB-231 cells without any treatment and transfected with a scrambled sequence as blank control and negative control.Results: The lentiviral vectors with UBE3 A shRNA expression were successfully constructed and the UBE3 A shRNA sequence with highest interreference efficiency was picked up(the inhibitory rate was 89.5% for UBE3 A gene and 45.3% for UBE3 A protein). Compared with the cells in blank control group, the proliferative and invasion abilities were significantly decreased with significant S-phase cell cycle arrest in MDA-MB-231 cells with UBE3 A down-regulation(all P<0.05); all the observed indexes in cells of negative control group showed no significant changes(all P>0.05). Conclusion: Down-regulating UBE3 A expression can induce cell cycle arrest in TNBC cells and thereby inhibit their proliferation and invasion abilities, and suggests that UBE3 A expression plays an important role in the malignant biological behaviors of TNBC cells.
作者 谢少利 王碧娟 刘家有 李金穗 赵小波 邓世山 侯令密 XIE Shaoli;WANG Bijuan;LIU Jiayou;LI Jinsui;ZHAO Xiaobo;DENG Shishan;HOU Lingmi(Department of Thyroid and Breast Surgery,the Affiliated Hospital of North Sichuan Medical College,Nanchong,Sichuan637000,China;Department of Internal Medicine,the Second Affiliated Hospital of North Sichuan Medical College,Nanchong,Sichuan637000,China;Department of Anatomy,North Sichuan Medical College,Nanchong,Sichuan637000,China)
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2018年第11期1417-1423,共7页 China Journal of General Surgery
基金 国家自然科学基金资助项目(81172496) 川北医学院课题资助项目(CBY16-A-YB14) 四川省南充市校科技战略合作项目(18SXHZ0555)
关键词 三阴性乳腺癌 泛素蛋白连接酶类 RNA干扰 细胞周期 Triple Negative Breast Neoplasms Ubiquitin-Protein Ligases RNA Interference Cell Cycle
  • 相关文献

参考文献2

二级参考文献24

  • 1侯令密,幸天勇,邓世山.AnnexinA2与乳腺癌关系的研究进展[J].中华临床医师杂志(电子版),2011,5(14):4206-4208. 被引量:2
  • 2幸天勇,侯令密,汪建国,赵小波,高砚春,邓世山.膜联蛋白A2在人乳腺癌组织中的差异表达及意义[J].中华临床医师杂志(电子版),2011,5(18):5310-5313. 被引量:2
  • 3Dhillon S. Trastuzumab emtansine: a review of its use in patients with HER2-positive advanced breast cancer previously treated with trastuzumab-based therapy[J]. Drugs, 2014, 74 (6) : 675-686.
  • 4Hagan CR, Lange CA. Molecular determinants of context- dependent progesterone receptor action in breast cancer [J]. BMC Med, 2014, 12: 32.
  • 5Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine[J]. NEnglJ Med, 2012, 366(6): 489-491.
  • 6Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or earboplatin-paclitaxel in pulmonary adenoeareinoma[J]. N Engl J Med, 2009, 361(10): 947-957.
  • 7Knutson TP, Lange CA. Tracking progesterone receptor- mediated actions in breast cancer[J]. Pharmacol Ther, 2014, 142(1) : 114-125.
  • 8Sachdev D. Targeting the type I insulin-like growth factor system for breast cancer therapy[J]. Curt Drug Targets, 2010, 11(9): 1121-1132.
  • 9Shimizu A, Nakayama H, Wang P, et al. Netrin-i promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein [J]. J Biol Chem, 2013, 288(4): 2210-2222.
  • 10Zhang Q, Zhao Z, Ma Y, et al. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma[J].Urol Oncol, 2014, 32(6): 798-805.

共引文献3

同被引文献6

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部